CALANDRA BUONAURA, Sebastiano
 Distribuzione geografica
Continente #
NA - Nord America 21.284
AS - Asia 8.908
EU - Europa 7.731
SA - Sud America 1.292
AF - Africa 187
Continente sconosciuto - Info sul continente non disponibili 175
OC - Oceania 17
Totale 39.594
Nazione #
US - Stati Uniti d'America 20.813
SG - Singapore 3.242
GB - Regno Unito 2.575
CN - Cina 2.195
IT - Italia 1.747
BR - Brasile 990
HK - Hong Kong 983
VN - Vietnam 821
SE - Svezia 774
DE - Germania 563
BD - Bangladesh 453
FI - Finlandia 371
FR - Francia 355
UA - Ucraina 352
RU - Federazione Russa 351
KR - Corea 221
TR - Turchia 217
IN - India 208
CA - Canada 205
BG - Bulgaria 141
ID - Indonesia 118
NL - Olanda 114
AR - Argentina 96
MX - Messico 85
IE - Irlanda 72
IQ - Iraq 68
JP - Giappone 55
PL - Polonia 53
BE - Belgio 52
PK - Pakistan 51
ZA - Sudafrica 50
CO - Colombia 42
EC - Ecuador 42
ES - Italia 42
AE - Emirati Arabi Uniti 40
CL - Cile 39
CR - Costa Rica 29
CZ - Repubblica Ceca 27
AT - Austria 26
SA - Arabia Saudita 24
VE - Venezuela 24
JM - Giamaica 22
KE - Kenya 22
MA - Marocco 21
EG - Egitto 20
TN - Tunisia 20
UZ - Uzbekistan 20
MY - Malesia 19
SV - El Salvador 19
PY - Paraguay 18
TT - Trinidad e Tobago 18
BZ - Belize 17
CH - Svizzera 17
DZ - Algeria 17
IR - Iran 17
LT - Lituania 16
PE - Perù 16
PR - Porto Rico 16
UY - Uruguay 16
AU - Australia 15
PH - Filippine 15
BA - Bosnia-Erzegovina 14
JO - Giordania 14
GT - Guatemala 13
IL - Israele 13
NI - Nicaragua 13
HN - Honduras 12
PT - Portogallo 12
SC - Seychelles 12
TW - Taiwan 12
OM - Oman 11
AZ - Azerbaigian 10
KZ - Kazakistan 10
NP - Nepal 10
TH - Thailandia 10
RO - Romania 9
BH - Bahrain 8
BO - Bolivia 8
CW - ???statistics.table.value.countryCode.CW??? 8
DO - Repubblica Dominicana 8
EU - Europa 8
AL - Albania 6
DK - Danimarca 6
EE - Estonia 6
ET - Etiopia 6
KG - Kirghizistan 6
KW - Kuwait 6
SK - Slovacchia (Repubblica Slovacca) 6
HU - Ungheria 5
LB - Libano 5
BB - Barbados 4
GP - Guadalupe 4
GR - Grecia 4
HR - Croazia 4
SY - Repubblica araba siriana 4
XK - ???statistics.table.value.countryCode.XK??? 4
GE - Georgia 3
LK - Sri Lanka 3
NG - Nigeria 3
PS - Palestinian Territory 3
Totale 39.390
Città #
Ashburn 2.555
Singapore 2.117
Southend 1.865
Fairfield 1.753
Santa Clara 1.705
Woodbridge 1.212
San Jose 1.206
Houston 1.010
Hong Kong 963
Hefei 769
Chandler 751
Jacksonville 749
Seattle 715
Wilmington 619
Ann Arbor 616
Council Bluffs 578
Cambridge 560
Nyköping 458
Dearborn 445
London 376
Beijing 342
Los Angeles 300
Ho Chi Minh City 272
Helsinki 253
Milan 235
New York 221
The Dalles 220
Seoul 218
Chicago 210
Modena 209
Hanoi 192
San Diego 161
Columbus 155
Princeton 155
Sofia 134
Reading 130
Rome 127
Buffalo 126
Dallas 123
Lauterbourg 118
Eugene 115
São Paulo 105
Moscow 104
Shanghai 97
Des Moines 90
Izmir 88
Boardman 87
Grafing 82
Salt Lake City 80
Jakarta 78
Dublin 70
Naples 62
Munich 59
Orem 57
Phoenix 57
Atlanta 56
Da Nang 56
Washington 53
Toronto 50
Falls Church 49
Rio de Janeiro 46
Montreal 42
Tokyo 42
Bologna 41
Brussels 41
North Bergen 41
Brooklyn 40
Bremen 38
Elk Grove Village 38
Tampa 38
Warsaw 37
Frankfurt am Main 34
Newark 34
Saint Augustine 29
Franklin 28
Mexico City 28
Philadelphia 28
Redwood City 28
Belo Horizonte 27
Norwalk 27
Guangzhou 26
Nuremberg 26
Santiago 26
Turin 26
Chennai 25
Baghdad 23
Denver 23
Manchester 23
Nanjing 23
Detroit 22
Haiphong 22
Johannesburg 22
San Francisco 22
San Mateo 22
St Louis 22
Boston 21
Miami 21
Brno 20
Kent 20
Miano 20
Totale 27.580
Nome #
CASO CLINICO: QUANDO LA RISPOSTA ALLA DIETA IPOLIPIDEMIZZANTE DETERMINA LA DIAGNOSI 1.232
Familial hypercholesterolemia: The Italian Atherosclerosis Society Network (LIPIGEN) 547
Lysosomal lipase deficiency: Molecular characterization of eleven patients with Wolman or cholesteryl ester storage disease 422
Additive effect of mutations in LDLR and PCSK9 genes on the phenotype of familial hypercholesterolemia 418
A 'de novo' point mutation of the low-density lipoprotein receptor gene in an Italian subject with primary hypercholesterolemia 412
Hypertriglyceridaemia and low plasma HDL in a patient with apolipoprotein A-V deficiency due to a novel mutation in the APOA5 gene 407
Functional analysis of two novel splice site mutations of APOB gene in familial hypobetalipoproteinemia 402
Spectrum of mutations and phenotypic expression in patients with autosomal dominant hypercholesterolemia identified in Italy 387
Inherited apolipoprotein A-V deficiency in severe hypertriglyceridemia 386
A study of fatty liver disease and plasma lipoproteins in a kindred with familial hypobetalipoproteinemia due to a novel truncated form of apolipoprotein B (apo B-54.5) 377
A novel deletion of BRCA1 gene that eliminates the ATG initiation codon without affecting the promoter region 377
Spectrum of mutations in Italian patients with familial hypercholesterolemia: New results from the LIPIGEN study 376
Abnormal splicing of ABCA1 pre-mRNA in Tangier disease due to a IVS2+5G > C mutation in ABCA1 gene 376
Novel mutations in SAR1B and MTTP genes in Tunisian children with chylomicron retention disease and abetalipoproteinemia. 375
Abnormal apolipoprotein B pre-mRNA splicing in patients with familial hypobetalipoproteinaemia 374
Altered mRNA splicing in lipoprotein disorders 374
A novel homozygous mutation in CETP gene as a cause of CETP deficiency in a caucasian kindred 367
Clinical characteristics and plasma lipids in subjects with familial combined hypolipidemia: a pooled analysis. 358
Rearrangements of the ABCC6 gene in Italian patients with PXE 354
Absence of apolipoprotein B-48 in the chick, Gallus domesticus 354
An apparent inconsistency in parent to offspring transmission ofpoint mutations of LDLR gene in familial hypercholesterolemia 353
APOA5 and trigliceride metabolism, lesson from human APOA5 deficiency. 350
Adaptor protein ARH is recruited to the plasma membrane by low density lipoprotein (LDL) binding and modulates endocytosis of the LDL/LDL receptor complex in hepatocytes 349
A point mutation in the lariat branch point of intron 6 of NPC1 as the cause of abnormal pre-mRNA splicing in Niemann-Pick type C disease. 347
Incidental finding of severe hypertriglyceridemia in children. Role of multiple rare variants in genes affecting plasma triglyceride. 345
MOLECULAR CHARACTERIZATION OF TWO PATIENTS WITH SEVERE LCAT DEFICIENCY 342
A novel sequence variant in APOA5 gene found in patients with severe hypertriglyceridemia 341
Pseudoxanthoma elasticum and familial hypercholesterolemia: A deleterious combination of cardiovascular risk factors 338
Clinical and genetic features of 3 patients with familial chylomicronemia due to mutations in GPIHBP1 gene 338
Identification and characterization of novel loss of function mutations in ATP-binding cassette transporter A1 in patients with low plasma high-density lipoprotein cholesterol. 337
Molecular diagnosis of hypobetalipoproteinemia: an ENID Review 337
Impact of rare variants in autosomal dominant hypercholesterolemia causing genes. 336
A point mutation in ABC1 gene in a patient with severe premature coronary heart disease and mild clinical phenotype of Tangier disease 331
Hypobetalipoproteinemia with an apparently recessive inheritance due to a de novo mutation of apolipoprotein B 327
Effect of ezetimibe coadministered with statins in genotype-confirmed heterozygous FH patients 327
Functional lecithin: Cholesterol acyltransferase Is not required for efficient atheroprotection in humans 326
Modulation of the synthesis of apolipoproteins in rat hepatoma cells. 325
A novel mutation in the sterol 27-hydroxylase gene of a woman with autosomal recessive cerebrotendinous xanthomatosis. 324
Plasma and urine lipoproteins during the development of nephrotic syndrome induced in the rat by adriamycin. 324
Multiple abnormally spliced ABCA1 mRNAs caused by a novel splice site mutation of ABCA1 gene in a patient with Tangier disease. 323
Separation of the isoprotein forms of apoprotein A-I of rat, rabbit and human HDL by combined isoelectrofocusing and SDS-polyacrylamide gel electrophoresis. 320
A 3-day-old neonate with severe hypertriglyceridemia from novel mutations of the GPIHBP1 gene 320
Two novel rare variants of APOA5 gene found in subjects with severe hypertriglyceridemia. 316
Autosomal recessive hypercholesterolemia (ARH) and homozygous familial hypercholesterolemia (FH): A phenotypic comparison 316
Leucine 10 allelic variant in signal peptide of PCSK9 increases the LDL cholesterol-lowering effect of statins in patients with familial hypercholesterolaemia. 312
Effect of the desulfation of heparin on its anticoagulant and anti-proliferative activity 309
Preemptive liver transplantation in a child with familial hypercholesterolemia 309
Denaturing high-performance liquid chromatography in the detection of ABCA1 gene mutations in familial HDL deficiency 308
Sequential expression during postnatal development of specific markers of junctional and free sarcoplasmic reticulum in chicken pectoralis muscle. 307
Homozygous familial hypercholesterolemia in Italy: Clinical and molecular features 306
Molecular analysis of NPC1 and NPC2 gene in 34 Niemann-Pick C Italian Patients: Identification and structural modeling of novel mutations 305
Mutations in MTP gene in abeta- and hypobeta-lipoproteinemia 303
Severe HDL deficiency due to novel defects in the ABCA1 transporter 303
Cholesteryl Ester Storage Disease (CESD) due to novel mutations in the LIPA gene 302
Analysis of LDL receptor gene mutations in Italian patients with homozygous familial hypercholesterolemia 300
Familial HDL deficiency due to ABCA1 gene mutations with or without other genetic lipoprotein disorders 299
Isoforms of rat apolipoprotein A-I isolated from the lipoproteins of hepatic Golgi apparatus and plasma. 296
Cholesterol synthesis in isolated rat hepatocytes: effect of homologous and heterologous serum lipoproteins. 296
Adult-onset Niemann-Pick type C disease: A clinical, neuroimaging, and molecular genetic study 294
Variable phenotypic expression of homozygous familial hypobetalipoproteinaemia due to novel APOB gene mutations 291
A novel mutation of the apolipoprotein A-I gene in a family with familial combined hyperlipidemia 287
Characterization of three mutations of the low density lipoprotein receptor gene in Italian patients with familial hypercholesterolemia. 286
Genetic polymorphisms affecting the phenotypic expression of familial hypercholesterolemia 283
Spectrum of mutations of the LPL gene identified in Italy in patients with severe hypertriglyceridemia 283
Quantitative polymerase chain reaction and microchip electrophoresis to detect major rearrangements of the low-density lipoprotein receptor gene causing familial hypercholesterolemia 280
Apolipoprotein B-100 production and cholesteryl ester content in the liver of developing chick 280
A large deletion in the LDL receptor gene--the cause of familial hypercholesterolemia in three Italian families: a study that dates back to the 17th century (FH-Pavia 279
Effect of a thromboxane A2 synthase inhibitor on the dyslipoproteinemia of an inbred rat strain with spontaneous age-related nephrotic syndrome 278
Pravastatin in heterozygous familial hypercholesterolemia: low-density lipoprotein (LDL) cholesterol-lowering effect and LDL receptor activity on skin fibroblastS. 275
Severe hypertriglyceridemia in a newborn with monogenic lipoprotein lipase deficiency: an unconventional therapeutic approach with exchange transfusion. 274
Fatty liver in heterozygous hypobetalipoproteinemia caused by a novel truncated form of apolipoprotein B 273
Mechanisms and genetic determinants regulating sterol absorption, circulating LDL levels, and sterol elimination: implications for classification and disease risk. 268
Plasma lipoproteins in rats with experimental biliary obstruction. II. An ultrastructural study. 267
Changes of the main isoform of human apolipoprotein A-I following incubation of plasma. 264
Characterization of Three Kindreds with Familial Combined Hypolipidemia Due to Loss of Function Mutations of ANGPTL3. 264
Evaluation of the performance of Dutch Lipid Clinic Network score in an Italian FH population: The LIPIGEN study 263
Secretion of lipoproteins, apolipoprotein A-I and apolipoprotein E by isolated and perfused liver of rat with experimental nephrotic syndrome. 260
β-thalassemia is a modifying factor of the clinical expression of familial hypercholesterolemia 259
Experimental nephrotic syndrome in the rat induced by puromycin aminonucleoside: hepatic synthesis of lipoproteins and apolipoproteins. 259
Partial duplication of the EGF precursor homology domain of the LDL receptor protein causing familial hypercholesterolemia (FH-Salerno) 258
The molecular basis of lecithin: Cholesterol acyltransferase deficiency syndromes: A comprehensive study of molecular and biochemical findings in 13 unrelated Italian families 256
Worldwide experience of homozygous familial hypercholesterolaemia: retrospective cohort study 256
Combined monogenic hypercholesterolemia and hypoalphalipoproteinemia caused by mutations in LDL-R and LCAT genes 255
Genetics and molecular biology: proprotein convertase subtilisin/kexin type 9 and LDL receptor--an intriguing story. 253
Heavy metals and experimental atherosclerosis. Effect of lead intoxication on rabbit plasma lipoproteins. 252
Duplication of exons 13, 14 and 15 of the LDL-receptor gene in a patients with heterozygous familial hypercholesterolemia 252
Secretion of apoB- and apoA-I-containing lipoproteins by chick kidney 251
Therapeutic management of a new case of LCAT deficiency with a multifactorial long-term approach based on high doses of angiotensin II receptor blockers (ARBs). 250
Synthesis and secretion of B-100 and A-I apolipoproteins in response to the changes of intracellular cholesteryl ester content in chick liver 247
Synthesis and secretion of apolipoprotein A-I by chick skin. 247
Lung involvement in Niemann-Pick disease type C1: improvement with bronchoalveolar lavage 246
Plasma and urinary lipids and lipoproteins during the development of nephrotic syndrome induced in the rat by puromycin aminonucleoside. 243
In vitro functional characterization of splicing variants of the APOB gene found in familial hypobetalipoproteinemia 243
Plasma lecithin: cholesterol acyltransferase activity in liver disease. 242
Novel mutations of SAR1B gene in four children with chylomicron retention disease 241
Angiopoietin-like protein 3 (ANGPTL3) deficiency and familial combined hypolipidemia 240
A man with low cholesterol and weakness of the lower limbs. 240
The type of LDLR gene mutationpredicts cardiovascular risk in children with familial hypercholesterolemia. 233
Changes in apolipoprotein A-I mRNA level in the liver of rats with experimental nephrotic syndrome 233
Experimental nephrotic syndrome in the rat induced by puromycin aminonucleoside. Plasma and urinary lipoproteins 232
Totale 31.859
Categoria #
all - tutte 151.169
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 151.169


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.789 0 0 0 0 55 210 204 103 284 178 494 261
2022/20232.390 258 267 163 197 285 383 37 213 324 53 99 111
2023/20241.564 66 78 144 141 292 162 150 162 56 90 40 183
2024/20256.147 196 52 118 406 1.129 968 592 340 534 191 712 909
2025/202611.918 788 548 973 1.144 1.925 810 1.520 595 993 1.195 758 669
2026/20273.746 528 675 892 1.297 354 0 0 0 0 0 0 0
Totale 39.594